Zynerba Pharmaceuticals
0 sources
Financials
0001558370-21-002669Zynerba Pharmaceuticals
Summary
Zynerba Pharmaceuticals is a business[1].
Key Facts
- Zynerba Pharmaceuticals is in the country of United States[2].
- Zynerba Pharmaceuticals is in the country of US[3].
- Zynerba Pharmaceuticals's instance of is recorded as business[4].
- Zynerba Pharmaceuticals's instance of is recorded as public company[5].
- Zynerba Pharmaceuticals's headquarters location is recorded as Radnor[6].
- Zynerba Pharmaceuticals's stock exchange is recorded as Nasdaq[7].
- January 1, 2014 marks the founding of Zynerba Pharmaceuticals[8].
- 2007-01-31 marks the founding of Zynerba Pharmaceuticals[9].
- Zynerba Pharmaceuticals's official website is recorded as https://zynerba.com/[10].
- Zynerba Pharmaceuticals's legal form is recorded as Delaware corporation[11].
- Zynerba Pharmaceuticals's legal form is recorded as XTIQ[12].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 549300JLJ5VQU2CN6016[13]
-
Registered legal name: Zynerba Pharmaceuticals, INC.[14]
-
Legal jurisdiction: US-DE[15]
-
GLEIF entity category: GENERAL[16]
-
Legal form (ISO 20275 ELF): XTIQ[17]
-
Entity status: ACTIVE[18]
-
LEI registration status: LAPSED[19]
-
Entity created: 2007-01-31[20]
-
LEI first registered: 2015-07-17[21]
-
LEI last updated: 2023-08-04[22]
-
LEI next renewal: 2023-04-20[23]
-
Managing LOU: 5493001KJTIIGC8Y1R12[24]
-
Registration authority: RA000602[25]
-
Authority entity ID: 4294230[26]
-
Conformity flag: NON_CONFORMING[27]
Body
Founding
Recorded inception include January 1, 2014[8] and 2007-01-31[9].
Operations
Zynerba Pharmaceuticals's headquarters location is recorded as Radnor[6].
Ownership
Zynerba Pharmaceuticals's stock exchange is recorded as Nasdaq[7].